Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492. PMID: 30207593.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, and Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249. https://doi.org/10.3322/caac.21660. PMID: 33538338.

Yoshikawa T, Rino Y, Yukawa N, Oshima T, Tsuburaya A, Masuda M. Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today. 2014;44(1):11–21. https://doi.org/10.1007/s00595-013-0529-1. Epub 2013 Mar 19 PMID: 23508452.

Article  CAS  PubMed  Google Scholar 

Kanda M, Kodera Y, Sakamoto J. Updated evidence on adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol. 2015;9(12):1549–60. https://doi.org/10.1586/17474124.2015.1094373. Epub 2015 Sep 28 PMID: 26414453.

Article  CAS  PubMed  Google Scholar 

Aoyama T, Yoshikawa T. Adjuvant therapy for locally advanced gastric cancer. Surg Today. 2017;47(11):1295–302. https://doi.org/10.1007/s00595-017-1493-y. Epub 2017 Mar 1 PMID: 28251375.

Article  PubMed  Google Scholar 

Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY. Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol. 2019;30:19–33. https://doi.org/10.1093/annonc/mdy502. PMID: 30475956.

Article  CAS  PubMed  Google Scholar 

Pentheroudakis G, ESMO Guidelines Committee. Recent eUpdates to the ESMO clinical practice guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancer. Ann Oncol. 2019;30:1395–7. https://doi.org/10.1093/annonc/mdz180. PMID: 31168599.

Article  CAS  PubMed  Google Scholar 

Aoyama T, Hara K, Kazama K, Maezawa Y. Clinical impact of nutrition and inflammation assessment tools in gastric cancer treatment. Anticancer Res. 2022;42(11):5167–80. https://doi.org/10.21873/anticanres.16023. PMID: 36288879.

Article  CAS  PubMed  Google Scholar 

Booka E, Kikuchi H, Haneda R, Soneda W, Kawata S, Murakami T, Matsumoto T, Hiramatsu Y, Takeuchi H. Neutrophil-to-lymphocyte ratio to predict the efficacy of immune checkpoint inhibitor in upper gastrointestinal cancer. Anticancer Res. 2022;42(6):2977–87. https://doi.org/10.21873/anticanres.15781. PMID: 35641297.

Article  CAS  PubMed  Google Scholar 

Ohsawa M, Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Hirohata R, Kitasaki N, Okada M. Neutrophil-to-lymphocyte ratio as a predictor of postoperative recurrence and prognosis in oesophageal squamous cell carcinoma. Anticancer Res. 2022;42(3):1499–507. https://doi.org/10.21873/anticanres.15622. PMID: 35220245.

Article  PubMed  Google Scholar 

Mazaki J, Katsumata K, Sujino H, Udo R, Tago T, Kasahara K, Kuwabara H, Enomoto M, Ishizaki T, Nagakawa Y, Tsuchida A. Neutrophil-to-lymphocyte ratio as a prognostic factor for colon cancer in elderly patients: a propensity score analysis. Anticancer Res. 2021;41(9):4471–8. https://doi.org/10.21873/anticanres.15256. PMID: 34475071.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12. https://doi.org/10.1007/s10120-011-0041-5. PMID: 21573743.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20. https://doi.org/10.1056/NEJMoa072252. Erratum in: N Engl J Med. 2008 May 1;358(18):1977. PMID: 17978289.

Article  CAS  PubMed  Google Scholar 

Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH, CLASSIC Trial Investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21. https://doi.org/10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7 PMID: 22226517.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 2019;37(15):1296–304. https://doi.org/10.1200/JCO.18.01138. Epub 2019 Mar 29. PMID: 30925125; PMCID: PMC6524985.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR, Tao M, Lian L, Li W. Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10(6):3411–8. https://doi.org/10.3892/ol.2015.3783. Epub 2015 Oct 8. PMID: 26788143; PMCID: PMC4665714.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Min KW, Kwon MJ, Kim DH, Son BK, Kim EK, Oh YH, Wi YC. Persistent elevation of postoperative neutrophil-to-lymphocyte ratio: a better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio. Sci Rep. 2017;7(1):13967. https://doi.org/10.1038/s41598-017-13969-x.PMID:29070814;PMCID:PMC5656603.

Article  PubMed  PubMed Central  Google Scholar 

Tamagawa H, Aoyama T, Numata M, Kazama K, Atsumi Y, Iguchi K, Ju M, Sawazaki S, Sato S, Kano K, Ohshima T, Yamada T, Godai T, Higuchi A, Saeki H, Yukawa N, Rino Y. Impact of infectious complications on survival and recurrence of patients with stage II/III colorectal cancer: a multicenter retrospective study. Anticancer Res. 2022;42(5):2763–9. https://doi.org/10.21873/anticanres.15755. PMID: 35489757.

Article  PubMed  Google Scholar 

Maezawa Y, Aoyama T, Ju M, Komori K, Kano K, Sawazaki S, Numata M, Hayashi T, Yamada T, Tamagawa H, Sato T, Ogata T, Cho H, Oshima T, Yukawa N, Yoshikawa T, Masuda M, Rino Y. The impact of severe infectious complications on long-term prognosis for gastric cancer. Anticancer Res. 2020;40(7):4067–74. https://doi.org/10.21873/anticanres.14404. PMID: 32620654.

Article  CAS  PubMed  Google Scholar 

Aoyama T, Kazama K, Atsumi Y, Tamagawa H, Tamagawa A, Komori K, Machida D, Maezawa Y, Kano K, Hara K, Murakawa M, Numata M, Oshima T, Yukawa N, Masuda M, Rino Y. Clinical influence of anastomotic leakage on esophageal cancer survival and recurrence. Anticancer Res. 2020;40(1):443–9. https://doi.org/10.21873/anticanres.13972. PMID: 31892599.

Article  PubMed  Google Scholar 

Hoshino S, Takeuchi M, Kawakubo H, Kobayashi R, Matsuda S, Irino T, Fukuda K, Nakamura R, Kitagawa Y. Neutrophil-to-lymphocyte ratio change predicts histological response to and oncological outcome of neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus. 2022;19(3):426–35. https://doi.org/10.1007/s10388-021-00901-6. Epub 2022 Jan 21 PMID: 35059908.

Article  PubMed  Google Scholar